These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 11587363)
1. Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins. Heibert SW; Lutterbach B; Durst K; Wang L; Linggi B; Wu S; Wood L; Amann J; King D; Hou Y Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S31-4. PubMed ID: 11587363 [TBL] [Abstract][Full Text] [Related]
2. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain. Durst KL; Lutterbach B; Kummalue T; Friedman AD; Hiebert SW Mol Cell Biol; 2003 Jan; 23(2):607-19. PubMed ID: 12509458 [TBL] [Abstract][Full Text] [Related]
3. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Fenrick R; Amann JM; Lutterbach B; Wang L; Westendorf JJ; Downing JR; Hiebert SW Mol Cell Biol; 1999 Oct; 19(10):6566-74. PubMed ID: 10490596 [TBL] [Abstract][Full Text] [Related]
4. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Amann JM; Nip J; Strom DK; Lutterbach B; Harada H; Lenny N; Downing JR; Meyers S; Hiebert SW Mol Cell Biol; 2001 Oct; 21(19):6470-83. PubMed ID: 11533236 [TBL] [Abstract][Full Text] [Related]
5. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Lutterbach B; Westendorf JJ; Linggi B; Patten A; Moniwa M; Davie JR; Huynh KD; Bardwell VJ; Lavinsky RM; Rosenfeld MG; Glass C; Seto E; Hiebert SW Mol Cell Biol; 1998 Dec; 18(12):7176-84. PubMed ID: 9819404 [TBL] [Abstract][Full Text] [Related]
6. The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor. Lutterbach B; Hou Y; Durst KL; Hiebert SW Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12822-7. PubMed ID: 10536006 [TBL] [Abstract][Full Text] [Related]
7. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Wang J; Hoshino T; Redner RL; Kajigaya S; Liu JM Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10860-5. PubMed ID: 9724795 [TBL] [Abstract][Full Text] [Related]
8. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias. Lo Coco F; Pisegna S; Diverio D Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of transcriptional repression by TEL/RUNX1 fusion protein. Lee YJ; Kim JH; Bae S; Rho SK; Choe SY Mol Cells; 2004 Apr; 17(2):217-22. PubMed ID: 15179033 [TBL] [Abstract][Full Text] [Related]
10. Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Guidez F; Petrie K; Ford AM; Lu H; Bennett CA; MacGregor A; Hannemann J; Ito Y; Ghysdael J; Greaves M; Wiedemann LM; Zelent A Blood; 2000 Oct; 96(7):2557-61. PubMed ID: 11001911 [TBL] [Abstract][Full Text] [Related]
11. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein. Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081 [TBL] [Abstract][Full Text] [Related]
12. Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins. Hiebert SW; Lutterbach B; Amann J Curr Opin Hematol; 2001 Jul; 8(4):197-200. PubMed ID: 11561155 [TBL] [Abstract][Full Text] [Related]
14. Multiple regions of ETO cooperate in transcriptional repression. Hildebrand D; Tiefenbach J; Heinzel T; Grez M; Maurer AB J Biol Chem; 2001 Mar; 276(13):9889-95. PubMed ID: 11150306 [TBL] [Abstract][Full Text] [Related]
15. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Wang L; Hiebert SW Oncogene; 2001 Jun; 20(28):3716-25. PubMed ID: 11439334 [TBL] [Abstract][Full Text] [Related]
16. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Gelmetti V; Zhang J; Fanelli M; Minucci S; Pelicci PG; Lazar MA Mol Cell Biol; 1998 Dec; 18(12):7185-91. PubMed ID: 9819405 [TBL] [Abstract][Full Text] [Related]
17. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Meyers S; Lenny N; Sun W; Hiebert SW Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369 [TBL] [Abstract][Full Text] [Related]
18. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein. Melnick AM; Westendorf JJ; Polinger A; Carlile GW; Arai S; Ball HJ; Lutterbach B; Hiebert SW; Licht JD Mol Cell Biol; 2000 Mar; 20(6):2075-86. PubMed ID: 10688654 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML. Guo C; Li J; Steinauer N; Wong M; Wu B; Dickson A; Kalkum M; Zhang J J Biol Chem; 2020 Mar; 295(13):4212-4223. PubMed ID: 32071087 [TBL] [Abstract][Full Text] [Related]
20. Domains involved in ETO and human N-CoR interaction and ETO transcription repression. Wang J; Wang M; Liu JM Leuk Res; 2004 Apr; 28(4):409-14. PubMed ID: 15109542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]